Previous 10 | Next 10 |
MINNEAPOLIS, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the pricing of a public offering of 150,000 units (th...
2023-10-12 10:00:14 ET More on Health Care Select Sector SPDR BofA reports 10th consecutive week of equity inflows Citi turns cautious on pharmaceuticals and biotech Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR For further details see...
2023-10-10 13:10:42 ET More on 5E Advanced Materials 5E Advanced Materials, Inc. (FEAM) Q4 2023 Earnings Call Transcript 5E Advanced Materials hires new contractors to complete small scale boron facility Seeking Alpha’s Quant Rating on 5E Advanced Materials ...
MINNEAPOLIS, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (Nuwellis), a medical technology company dedicated to transforming the lives of people with fluid overload, today announced that its distribution partner, SeaStar Medical (SeaStar), received correspondence from the U.S. ...
2023-08-08 10:55:05 ET Nuwellis, Inc. (NUWE) Q2 2023 Earnings Conference Call August 08, 2023 09:00 AM ET Company Participants Vivian Cervantes - Investor Relations Nestor Jaramillo - President & Chief Executive Officer John Jefferies - Chief Medical Officer ...
2023-08-08 08:19:45 ET Nuwellis press release ( NASDAQ: NUWE ): Q2 GAAP EPS of -$3.65 beats by $0.37 . Revenue of $2.1M (-6% Y/Y) misses by $0.09M . Utilization, or the number of circuits per console, increased 14% over the same period last year, reflecting an ...
MINNEAPOLIS, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of people with fluid overload, today reported financial results for the second quarter ended June 30, 2023. Revenue of $2.1 million for the second...
2023-08-08 08:14:11 ET Nuwellis ( NASDAQ: NUWE ) has announced that Lynn Blake will be transitioning from her role as CFO to pursue broader career goals. To ensure a smooth transition, Ms. Blake has agreed to remain in her current role through Sept. 1, 2023 and then consul...
MINNEAPOLIS, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of people with fluid overload, announced today that Lynn Blake will be transitioning from her role as Chief Financial Officer to pursue broader career goa...
2023-08-07 12:50:31 ET Nuwellis ( NASDAQ: NUWE ) is scheduled to announce Q2 earnings results on Tuesday, August 8th, before market open. The consensus EPS Estimate is -$4.02 and the consensus Revenue Estimate is $2.19M For further details see: Nuwellis Q2 Earnin...
News, Short Squeeze, Breakout and More Instantly...
MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the second quarter of 2024 on Tuesday, August 13, 2024. Nuwellis w...
MINNEAPOLIS, July 17, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, is proud to announce its first commercial sale of QUELIMMUNE™, a novel therapy developed by SeaS...
DENVER, July 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports the initial commercial sale of QUELIMMUNE ™ -Pediatric to its U.S. license and distribution partner, Nuwellis, Inc. QUELIMMUNE is SeaStar Medical’s Sel...